NFKB1 and diffuse large B-cell lymphoma: Since ABC-DLBCL cells depend on constitutive NF-κB signaling for proliferation and survival [11, 13–15], our observation that doxycycline inhibits NF-κB signaling predicts the drug would inhibit the growth of these cells.